Skip to content

Septerna, Inc. SEPN Total Revenue

Total Revenue at other companies

Amgen logo
AmgenAMGN
$8.62B+5.8%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.23M-96.1%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$20M
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$6.25M-66.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$636.5M-2.3%
Precigen logo
PrecigenPGEN
$23.25M+1,634%

Other financials

Income statement

See full
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s total revenue?
Septerna, Inc. (SEPN) reported total revenue of $26.52M in Q1 2026.
How has Septerna, Inc.'s total revenue changed year-over-year?
Septerna, Inc.'s total revenue increased by 12011.0% year-over-year, from $219K to $26.52M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.